Union Savings Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Hold
3,500
0.74% 21
2026
Q1
$1.97M Hold
3,500
0.86% 19
2025
Q4
$2.37M Buy
+3,500
New +$2.38M 1.03% 17
2025
Q2
$2.14M Hold
4,000
0.98% 18
2025
Q1
$1.68M Hold
4,000
0.82% 23
2024
Q4
$1.65M Hold
4,000
0.81% 23
2024
Q3
$2.02M Hold
4,000
0.99% 16
2024
Q2
$1.95M Hold
4,000
1.02% 16
2024
Q1
$2.16M Hold
4,000
1.13% 14
2023
Q4
$2.22M Sell
4,000
-436
-10% -$205K 1.26% 12
2023
Q3
$1.94M Hold
4,436
1.21% 15
2023
Q2
$2.46M Buy
+4,436
New +$2.13M 1.47% 10

Other funds holding IDXX

Union Savings Bank's IDXX Position: Q2 2026 in Review

Union Savings Bank held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 3,500 shares worth $1.84M. The position accounts for 0.74% of the portfolio, ranked #21.

Union Savings Bank first reported a position in IDXX in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.46M in Q2 2023. 454 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Union Savings Bank held 3,500 shares of Idexx Laboratories worth $1.84M as of Q2 2026.
  • Union Savings Bank left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.74% of Union Savings Bank's portfolio in Q2 2026, its #21 holding.
  • Union Savings Bank first reported a position in Idexx Laboratories in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's Idexx Laboratories position peaked at $2.46M in Q2 2023.
  • 454 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.